Diplomat Pharmacy (DPLO) Tops Q1 EPS by 4c, Offers FY Guidance

Diplomat Pharmacy (NYSE: DPLO) reported Q1 EPS of $0.19, $0.04 better than the analyst estimate of $0.15. Revenue for the quarter came in at $1.08 billion versus the consensus estimate of $1.08 billion.

GUIDANCE:

Diplomat Pharmacy sees FY2017 EPS of $0.54-$0.74, versus the consensus of $0.64. Diplomat Pharmacy sees FY2017 revenue of $4.3-4.7 billion, versus the consensus of $4.53 billion.

For earnings history and earnings-related data on Diplomat Pharmacy (DPLO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery